開示情報 > RaQualia Announces Launch of EP4 Antagonist GALLIPRANT in EU by Elanco Animal Health and Achievement of Milestone Payment from Aratana Therapeutics

RaQualia Announces Launch of EP4 Antagonist GALLIPRANT in EU by Elanco Animal Health and Achievement of Milestone Payment from Aratana Therapeutics

RaQualia Announces Launch of EP4 Antagonist GALLIPRANT in EU by Elanco Animal Health and Achievement of Milestone Payment from Aratana Therapeutics

開示者 【45790】ラクオリア創薬株式会社
文書名 RaQualia Announces Launch of EP4 Antagonist GALLIPRANT in EU by Elanco Animal Health and Achievement of Milestone Payment from Aratana Therapeutics  
PDF/XBRL [別ウインドウでPDFを開く]
開示日時 2019/04/12 チャネル/カテゴリ 東京証券取引所 /その他
ノート ログインするとIR文書にメモを入力して管理することができます
右上のログインメニューからログインしてください。


開示情報 > RaQualia Announces Launch of EP4 Antagonist GALLIPRANT in EU by Elanco Animal Health and Achievement of Milestone Payment from Aratana Therapeutics